| Previous close | 1.9000 |
| Open | 1.9900 |
| Bid | 1.8150 x 0 |
| Ask | 2.1400 x 0 |
| Day's range | 1.9500 - 2.1800 |
| 52-week range | 0.7920 - 4.9000 |
| Volume | |
| Avg. volume | 41,164 |
| Market cap | 38.725M |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6300 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireGabather reports initial positive results from the EEG/fMRI target engagement study
Gabather AB (Nasdaq First North Growth Market: GABA) today reports initial positive results from the EEG/fMRI target engagement study, a double-blinded placebo-controlled, cross-over phase Ib study of Gabather's GABAA-receptor positive allosteric modulator, GT-002, in healthy volunteers.
© 2024 Yahoo. All rights reserved.